Use of hydroxycinnamaldehyde glycoside derivatives for treating glomerulonephritis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9321795
APP PUB NO 20150299242A1
SERIAL NO

14693619

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a new use of a cinnamaldehyde derivative of formula (I) for treating glomerulonephritis (GN). Particularly, the present invention discloses that the cinnamaldehyde derivative of formula (I) is effective in treating glomerulonephritis (GN), which can alleviate various symptoms and signs of GN, including reducing proteinuria, serum blood urea nitrogen (BUN), glomerular cell proliferation, and renal macrophage/lymphocyte infiltration, etc.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NATIONAL DEFENSE MEDICAL CENTERNO 161 SEC 6 MINQUAN E RD NEIHU DIST TAIPEI 11490

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chao, Kuo-Ping Chiayi County, TW 3 1
Chen, Ann Taipei, TW 31 75
Chen, Shui-Tein Taipei, TW 19 76
Hua, Kuo-Feng I-Lan, TW 17 13
Ka, Shuk-Man Taipei, TW 25 24

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 26, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00